AJ Lanigan: Yes. The Truth is, pharma companies are producing significant money with treatment plans like Keytruda and Opdivo that offer with PD-1 and PD-L1. Listed here’s the super amazing portion: think about checkpoints as traffic alerts. You don’t want an immune procedure that’s functioning wild just like a freight waiting for link from Social Bookmarking